| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.09 |